Proteins > Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B
Page last updated: 2024-08-07 17:17:50
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B
[no definition available]
Synonyms
Research
Bioassay Publications (5)
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Compounds (7)
Drugs with Inhibition Measurements
The first two cantharidin analogues displaying PP1 selectivity.Bioorganic & medicinal chemistry letters, , Feb-11, Volume: 12, Issue:3, 2002
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.Journal of medicinal chemistry, , Mar-14, Volume: 45, Issue:6, 2002
Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.Bioorganic & medicinal chemistry letters, , Nov-19, Volume: 11, Issue:22, 2001
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.Journal of medicinal chemistry, , Mar-14, Volume: 45, Issue:6, 2002
A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.Journal of medicinal chemistry, , Sep-26, Volume: 40, Issue:20, 1997
Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2A.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 13, Issue:17, 2003
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.Journal of medicinal chemistry, , Mar-14, Volume: 45, Issue:6, 2002
The first two cantharidin analogues displaying PP1 selectivity.Bioorganic & medicinal chemistry letters, , Feb-11, Volume: 12, Issue:3, 2002
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.Journal of medicinal chemistry, , Mar-14, Volume: 45, Issue:6, 2002
A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.Journal of medicinal chemistry, , Sep-26, Volume: 40, Issue:20, 1997
The first two cantharidin analogues displaying PP1 selectivity.Bioorganic & medicinal chemistry letters, , Feb-11, Volume: 12, Issue:3, 2002
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.Journal of medicinal chemistry, , Mar-14, Volume: 45, Issue:6, 2002
A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.Journal of medicinal chemistry, , Sep-26, Volume: 40, Issue:20, 1997
The first two cantharidin analogues displaying PP1 selectivity.Bioorganic & medicinal chemistry letters, , Feb-11, Volume: 12, Issue:3, 2002
Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.Bioorganic & medicinal chemistry letters, , Nov-19, Volume: 11, Issue:22, 2001